7th Jun 2021 13:58
Scancell Holdings PLC - Oxford, England-based immunotherapies for treatment of cancer and infectious disease - Non-Executive Director Martin Diggle buys 400,000 shares via Vulpes Life Sciences Fund at 19.25 pence, worth about GBP77,000, on Friday last week. Diggle had bought 400,000 shares back at the end of April. Vulpes now has 117.0 million shares, a 14.4% stake.
Current stock price: 21.35p, up 8.1% on Monday
Year-to-date change: up 53%
By Tom Waite; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
Scancell Holdings